Valuation: Fisher & Paykel Healthcare Corporation Limited

Capitalization 22.26B 12.9B 10.95B 10.25B 9.6B 17.72B 1,172B 19.43B 120B 46.18B 551B 48.37B 47.36B 1,996B P/E ratio 2026 *
49.4x
P/E ratio 2027 * 42.3x
Enterprise value 22.01B 12.75B 10.83B 10.13B 9.5B 17.53B 1,159B 19.21B 118B 45.66B 545B 47.83B 46.83B 1,974B EV / Sales 2026 *
9.75x
EV / Sales 2027 * 8.69x
Free-Float
91.76%
Yield 2026 *
1.26%
Yield 2027 * 1.53%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Fisher & Paykel Healthcare Corporation Limited

1 day+0.19%
1 week-0.76%
Current month+1.61%
1 month+0.56%
3 months+0.53%
6 months+3.55%
Current year-1.30%
More quotes
1 week 37.3
Extreme 37.3
38.49
1 month 36.21
Extreme 36.21
40.46
Current year 31.8
Extreme 31.8
40.46
1 year 31.8
Extreme 31.8
40.46
3 years 20.29
Extreme 20.29
40.46
5 years 18.02
Extreme 18.02
40.46
10 years 8.13
Extreme 8.13
40.46
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 2016-03-31
Director of Finance/CFO - 2018-10-22
Chief Operating Officer - 2024-03-31
Director TitleAgeSince
Director/Board Member 67 2001-10-31
Director/Board Member 64 2016-03-31
Director/Board Member - 2017-05-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.19%-0.76%+2.99%+64.64% 12.88B
-0.95%+5.06%+13.11%+19.16% 223B
-0.82%-1.83%+20.21%+27.47% 126B
-2.44%+1.19%+48.52%+104.64% 67.96B
-1.56%+4.36%-13.41%-21.03% 57.11B
-0.29%+0.31%+19.23%+70.27% 52.41B
+0.05%-0.70%-13.80%-42.54% 25.64B
-0.90%-1.96%+19.52%+37.81% 24.94B
+0.48%+0.10%+8.69%-31.46% 23.72B
+1.18%-2.22%-24.06%+15.07% 21.76B
Average -0.50%+0.45%+8.10%+24.40% 63.62B
Weighted average by Cap. -0.89%+1.96%+13.95%+27.68%
See all sector performances

Financials

2026 *2027 *
Net sales 2.26B 1.31B 1.11B 1.04B 974M 1.8B 119B 1.97B 12.14B 4.69B 55.88B 4.91B 4.81B 203B 2.52B 1.46B 1.24B 1.16B 1.09B 2.01B 133B 2.2B 13.54B 5.22B 62.31B 5.47B 5.36B 226B
Net income 452M 262M 222M 208M 195M 360M 23.81B 395M 2.43B 938M 11.19B 982M 962M 40.55B 527M 305M 259M 243M 227M 420M 27.76B 460M 2.83B 1.09B 13.04B 1.15B 1.12B 47.28B
Net Debt -248M -144M -122M -114M -107M -198M -13.07B -217M -1.33B -515M -6.14B -539M -528M -22.26B -367M -213M -181M -169M -158M -292M -19.34B -320M -1.97B -762M -9.08B -798M -781M -32.93B
More financial data * Estimated data
Logo Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Employees
7,412
More about the company
Date Price Change Volume
25-12-15 37.90 $ +0.19% 393,153
25-12-15 37.83 $ +1.04% 377,681
25-12-12 37.44 $ -1.47% 300,469
25-12-11 38.00 $ +0.29% 441,621
25-12-10 37.89 $ -0.45% 557,187

End-of-day quote New Zealand S.E., December 15, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
37.90NZD
Average target price
39.33NZD
Spread / Average Target
+3.79%
Consensus

Quarterly revenue - Rate of surprise